Unity Biotechnology (FRA:9U90) Other Long Term Assets : €0.90 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Other Long Term Assets?

Unity Biotechnology's other long-term assets for the quarter that ended in Mar. 2025 was €0.90 Mil.

Unity Biotechnology's quarterly other long-term assets increased from Sep. 2024 (€0.99 Mil) to Dec. 2024 (€0.99 Mil) but then stayed the same from Dec. 2024 (€0.99 Mil) to Mar. 2025 (€0.90 Mil).

Unity Biotechnology's annual other long-term assets increased from Dec. 2022 (€0.89 Mil) to Dec. 2023 (€0.94 Mil) and increased from Dec. 2023 (€0.94 Mil) to Dec. 2024 (€0.99 Mil).

Unity Biotechnology Other Long Term Assets Historical Data

The historical data trend for Unity Biotechnology's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Other Long Term Assets Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

1.19

0.87

0.89

0.94

0.99

Unity Biotechnology Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															1.01	1.07	0.99	0.99	0.90

Unity Biotechnology Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Unity Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (FRA:9U90) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

UBX:USA 0YC0:UK

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Unity Biotechnology Headlines

No Headlines